From NAD+ elevation to clinical benefit: tissue-specific regulation and translational barriers in aging and age-related disease
- DOI
- 10.1016/j.phrs.2026.109743
- Published
- 2026-11
- Container
- Pharmacological Research
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.109743,
title = {From NAD+ elevation to clinical benefit: tissue-specific regulation and translational barriers in aging and age-related disease},
author = {Zerong Pei and Minyong Zhong and Qingxiang Jiang and Anhui Yang and Xuemei Wang and Fengni Liang and Hui Li},
year = {2026},
journal = {Pharmacological Research},
doi = {10.1016/j.phrs.2026.109743},
url = {https://doi.org/10.1016/j.phrs.2026.109743}
}RIS
TY - JOUR TI - From NAD+ elevation to clinical benefit: tissue-specific regulation and translational barriers in aging and age-related disease AU - Zerong Pei AU - Minyong Zhong AU - Qingxiang Jiang AU - Anhui Yang AU - Xuemei Wang AU - Fengni Liang AU - Hui Li PY - 2026 JO - Pharmacological Research DO - 10.1016/j.phrs.2026.109743 UR - https://doi.org/10.1016/j.phrs.2026.109743 ER -
APA
Pei, Z., Zhong, M., Jiang, Q., Yang, A., Wang, X., Liang, F., & Li, H. (2026). From NAD+ elevation to clinical benefit: tissue-specific regulation and translational barriers in aging and age-related disease. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.109743
Source records
- crossref · retrieved 2026-11-07T23:08:03.385Z